Journal of Natural Products · 2012 · 24 citations · 31 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsAntibiotic ResistanceMultidrug ResistanceNatural Product Drug DiscoveryStructure-activity Relationship AnalysisAntibiotic DiscoveryAntibiotic Resistance ScreeningAntimicrobial Drug DevelopmentFungal Bioactive CompoundsNatural Antimicrobials Against MoldsNovel Antibacterial AgentsNovel Antibacterial Drug DiscoveryRelative Configuration Determination
Drug-resistant bacteria continue to make many existing antibiotic classes ineffective. In order to avoid a future epidemic from drug-resistant bacterial infections, new antibiotics with new modes of action are needed. In an antibiotic screening program for new drug leads with new modes of action using antisense Staphylococcus aureus Fitness Test screening, we discovered a new tetramic acid, methiosetin, from a tropical sooty mold, Capnodium sp. The fungus also produced epicorazine A, a known antibiotic. The structure and relative configuration of methiosetin was elucidated by 2D NMR and ESIMS techniques. Methiosetin and epicorazine A showed weak to modest antibacterial activity against S. aureus and Haemophilus influenzae. The isolation, structure elucidation, and antibacterial activity of both compounds are described.
31
Clustal W and Clustal X version 2.0
Mark Larkin, Gordon Blackshields, Nigel P. Brown et al. · Bioinformatics · 2007 · 29.1K citations · Full text
Platensimycin is a selective FabF inhibitor with potent antibiotic properties
Jun Wang, S.M. Soisson, Katherine Young et al. · Nature · 2006 · 815 citations
Antibacterial Agents That Inhibit Lipid A Biosynthesis
Hiroshi Ōnishi, Barbara A. Pelak, Lynn S. Gerckens et al. · Science · 1996 · 410 citations